Health and Fitness Health and Fitness
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Amarillo Biosciences Issues Corporate Update
[ Fri, Oct 14th 2011 ] - Market Wire
Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors
[ Fri, Oct 14th 2011 ] - Market Wire
New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
[ Fri, Oct 14th 2011 ] - Market Wire
Dynavax to Present at Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.
[ Fri, Oct 14th 2011 ] - Market Wire
Teva Completes Acquisition of Cephalon
[ Fri, Oct 14th 2011 ] - Market Wire
Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M
[ Fri, Oct 14th 2011 ] - Market Wire
Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st
Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Trimel Appoints John Friedrichsen to Its Board of Director
[ Thu, Oct 13th 2011 ] - Market Wire
Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger
[ Thu, Oct 13th 2011 ] - Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire
[ Thu, Oct 13th 2011 ] - Market Wire
Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL
[ Thu, Oct 13th 2011 ] - Market Wire
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
[ Thu, Oct 13th 2011 ] - Market Wire
U.S. Sales of EGRIFTA(R) Driving Revenue Growth
[ Thu, Oct 13th 2011 ] - Market Wire
Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise
[ Thu, Oct 13th 2011 ] - Market Wire
China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
[ Wed, Oct 12th 2011 ] - Market Wire
Mylan Announces Intention to Refinance Existing Secured Credit Facility
[ Wed, Oct 12th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation
[ Wed, Oct 12th 2011 ] - Market Wire
Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors
[ Wed, Oct 12th 2011 ] - Market Wire
Ceapro Announces Signing of a Sales Agreement Wit .. s Inc. for its certified All-Natural Active Ingre
[ Wed, Oct 12th 2011 ] - Market Wire
OPKO Completes Sale of Ophthalmic Instrumentation Business
[ Wed, Oct 12th 2011 ] - Market Wire
Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm
[ Wed, Oct 12th 2011 ] - Market Wire
Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death
[ Wed, Oct 12th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation
[ Wed, Oct 12th 2011 ] - Market Wire
Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen
[ Tue, Oct 11th 2011 ] - Market Wire
Healthnostics Launching MicroFill-2160 1st Quarter 2012
[ Tue, Oct 11th 2011 ] - Market Wire
GlycoMimetics and Pfizer Enter into Licensing Agr .. rently in Development to Treat Patients Experienc
[ Tue, Oct 11th 2011 ] - Market Wire
Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter
[ Tue, Oct 11th 2011 ] - Market Wire
International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal
[ Tue, Oct 11th 2011 ] - Market Wire
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program
[ Tue, Oct 11th 2011 ] - Market Wire
Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
[ Tue, Oct 11th 2011 ] - Market Wire
Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
Electromed, Inc. Introduces aSeriously Pinka to Its SmartVest® Product Line
[ Mon, Oct 10th 2011 ] - Market Wire
Health Net Receives Full URAC Accreditation for Disease Management
[ Mon, Oct 10th 2011 ] - Market Wire
Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®
[ Fri, Oct 07th 2011 ] - Market Wire
NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Novadaq Reports 165 System Shipments During Third Quarter 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference
[ Thu, Oct 06th 2011 ] - Market Wire
Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A
[ Thu, Oct 06th 2011 ] - Market Wire
Greystone Logistics Announces Record Sales in 4th Quarter
[ Thu, Oct 06th 2011 ] - Market Wire
The Ensign Group Acquires La Jolla Skilled Nursing Facility
Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
Basilea receives request for extraordinary shareh .. lect additional members to the board of directors
[ Wed, Oct 05th 2011 ] - Market Wire
Waters Empowers Advantar Laboratories for Sustained Growth
[ Wed, Oct 05th 2011 ] - Market Wire
Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
Sangamo BioSciences to Host Conference Call to Di .. m Phase 2b Trial of SB-509 in Diabetic Neuropathy
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Aetna to Offer Individual Products to the National Association for the Self Employed
[ Thu, Sep 29th 2011 ] - Market Wire
Galectin Therapeutics Posts New Corporate Presentation Video to its Website
[ Thu, Sep 29th 2011 ] - Market Wire
SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors
[ Thu, Sep 29th 2011 ] - Market Wire
The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines
[ Thu, Sep 29th 2011 ] - Market Wire
Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest
[ Thu, Sep 29th 2011 ] - Market Wire
NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date
[ Thu, Sep 29th 2011 ] - Market Wire
Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
[ Thu, Sep 29th 2011 ] - Market Wire
Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year
Wed, September 28, 2011
[ Wed, Sep 28th 2011 ] - Market Wire
Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 28th 2011 ] - Market Wire
HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M
[ Wed, Sep 28th 2011 ] - Market Wire
BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain
[ Wed, Sep 28th 2011 ] - Market Wire
Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina
[ Wed, Sep 28th 2011 ] - Market Wire
Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent
[ Wed, Sep 28th 2011 ] - Market Wire
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
[ Wed, Sep 28th 2011 ] - Market Wire
IntegraMed Promotes Tim Sheehan to SVP and CFO
[ Wed, Sep 28th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products
[ Wed, Sep 28th 2011 ] - Market Wire
Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis
Tue, September 27, 2011
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland
[ Tue, Sep 27th 2011 ] - Market Wire
HCA Announces Proposed Public Offering of $500 Million Senior Notes
[ Tue, Sep 27th 2011 ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Massachusetts
[ Tue, Sep 27th 2011 ] - Market Wire
Merck Names Cuong Viet Do as Chief Strategy Officer
[ Tue, Sep 27th 2011 ] - Market Wire
POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast
[ Tue, Sep 27th 2011 ] - Market Wire
BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup, Healthways Release Inaugural Well-Being Index Results for Germany
[ Tue, Sep 27th 2011 ] - Market Wire
Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies
[ Tue, Sep 27th 2011 ] - Market Wire
Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en
[ Tue, Sep 27th 2011 ] - Market Wire
Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO
Mon, September 26, 2011
[ Mon, Sep 26th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of American Medical Alert Corp.
[ Mon, Sep 26th 2011 ] - Market Wire
Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of
[ Mon, Sep 26th 2011 ] - Market Wire
Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert
[ Mon, Sep 26th 2011 ] - Market Wire
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
[ Mon, Sep 26th 2011 ] - Market Wire
Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole
[ Mon, Sep 26th 2011 ] - Market Wire
Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors
[ Mon, Sep 26th 2011 ] - Market Wire
iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
[ Mon, Sep 26th 2011 ] - Market Wire
ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial
[ Mon, Sep 26th 2011 ] - Market Wire
Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin
[ Mon, Sep 26th 2011 ] - Market Wire
National Hospice and Palliative Care Expert Joins Amedisys
Sat, September 24, 2011
[ Sat, Sep 24th 2011 ] - Market Wire
FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu
[ Sat, Sep 24th 2011 ] - Market Wire
Approbation par la FDA de Soliris® (©culizumab) .. du syndrome h©molytique et ur©mique atypique (S
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. r©union annuelle de la?EMCC,;;; des
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual
Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ] - Market Wire
CytoDyn Announces Humanized Cytolin® Provisional .. t Application Filed for the Treatment of HIV/AIDS
[ Fri, Sep 23rd 2011 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene: reglementaire update inzake REVLIMID
[ Fri, Sep 23rd 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.
[ Fri, Sep 23rd 2011 ] - Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ] - Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien Anuncia Aumento de 12,5% em Dividendo
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien gibt Dividendenerhhung von 12,5 Prozent bekannt
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien annonce une augmentation de son dividende de 12,5 %
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien anuncia un aumento de dividendos del 12,5%
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien verhoogt kwartaaldividend met 12,5 procent
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien annuncia un aumento dei dividendi pari al 12,5%
[ Thu, Sep 22nd 2011 ] - Market Wire
Tunstall Healthcare Group Limited to Acquire AMAC, American Medical Alert Corp.
[ Thu, Sep 22nd 2011 ] - Market Wire
Bioniche Life Sciences Inc. Outlines Plan to Achieve Profitability
[ Thu, Sep 22nd 2011 ] - Market Wire
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities

American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price Deficiency with Respect to NYSE Listing Standard


//health-fitness.news-articles.net/content/2011/ .. iency-with-respect-to-nyse-listing-standard.html
Published in Health and Fitness on Thursday, October 6th 2011 at 18:41 GMT by Market Wire   Print publication without navigation


American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price... -- JERSEY CITY, N.J., Oct. 6, 2011 /PRNewswire-Asia-FirstCall/ --

American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price Deficiency with Respect to NYSE Listing Standard

[ ]

JERSEY CITY, N.J., Oct. 6, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: [ AOB ]), or (the "Company") today announced that the Company submitted its plan to cure stock price deficiency with respect to the listing standard of the New York Stock Exchange ("NYSE") on October 5, 2011.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.  

Safe Harbor Statement

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995.  Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements.  The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, may cause actual results or events to differ materially from those described in the forward looking statements in this press release.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

Contact:
Hong Zhu
646-367-1765

SOURCE American Oriental Bioengineering, Inc.

[ Back to top ]


Publication Contributing Sources